160 related articles for article (PubMed ID: 1428733)
1. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
Vats T; Buchanan G; Mehta P; Ragab A; Hvizdale E; Nitschke R; Link M; Beardsley GP; Maybee D; Krischer J
Invest New Drugs; 1992 Aug; 10(3):231-4. PubMed ID: 1428733
[TBL] [Abstract][Full Text] [Related]
2. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
[TBL] [Abstract][Full Text] [Related]
3. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
[TBL] [Abstract][Full Text] [Related]
5. Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone.
Weiss M; Maslak P; Feldman E; Berman E; Bertino J; Gee T; Megherian L; Seiter K; Scheinberg D; Golde D
J Clin Oncol; 1996 Sep; 14(9):2480-5. PubMed ID: 8823326
[TBL] [Abstract][Full Text] [Related]
6. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
[TBL] [Abstract][Full Text] [Related]
8. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
9. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
[TBL] [Abstract][Full Text] [Related]
10. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT
Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925
[TBL] [Abstract][Full Text] [Related]
11. Vindesine in the treatment of leukaemia.
Gökbuget N; Hoelzer D
Leuk Lymphoma; 1997 Aug; 26(5-6):497-506. PubMed ID: 9389357
[TBL] [Abstract][Full Text] [Related]
12. [Phase II study of vindesine in hematological malignancies].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
[TBL] [Abstract][Full Text] [Related]
14. A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.
Bajorin D; Kelsen DP
Cancer Invest; 1990; 8(2):135-41. PubMed ID: 1698110
[TBL] [Abstract][Full Text] [Related]
15. Treatment of relapsed or refractory adult acute lymphocytic leukemia.
Freund M; Diedrich H; Ganser A; Gramatzki M; Heil G; Heyll A; Henke M; Hiddemann W; Haas R; Kuse R
Cancer; 1992 Feb; 69(3):709-16. PubMed ID: 1730121
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
[No Abstract] [Full Text] [Related]
17. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
19. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
[TBL] [Abstract][Full Text] [Related]
20. Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Grozea PN; Fabian CJ; Dixon DO
Cancer Treat Rep; 1984; 68(7-8):963-7. PubMed ID: 6744347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
